Shanghai, China

Ji Yue Zhang

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 9.7

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: The Innovations of Ji Yue Zhang

Introduction

Ji Yue Zhang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target PRC2-mediated diseases. With a total of seven patents to his name, Zhang's work is recognized for its potential therapeutic applications.

Latest Patents

Zhang's latest patents include innovative compounds such as Triazolopyridine compounds and Imidazolepyridine compounds. The Triazolopyridine compound is described as a compound of Formula (IA), or a pharmaceutically acceptable salt thereof, which has been shown to be useful for treating a PRC2-mediated disease or disorder. Similarly, the Imidazolepyridine compound is also a compound of Formula (IA), or a pharmaceutically acceptable salt thereof, with similar therapeutic applications.

Career Highlights

Throughout his career, Ji Yue Zhang has worked with notable companies such as Novartis AG and Siemens Aktiengesellschaft. His experience in these organizations has allowed him to collaborate on various innovative projects and enhance his expertise in pharmaceutical research.

Collaborations

Zhang has collaborated with several professionals in his field, including Yuan Mi and Xingnian Fu. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Ji Yue Zhang's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in treating complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…